Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Emerging Views On Emerging Markets: Bank of America Merrill Lynch Global Healthcare Conference

This article was originally published in PharmAsia News

Executive Summary

In this periodic feature, PharmAsia News listens in at major industry events to hear what senior executives have to say about Asia and other emerging markets. In our last profile, we sat in on the recent Morgan Stanley Global Healthcare Conference in New York ('Emerging Views On Emerging Markets: Morgan Stanley Global Healthcare Conference,' PharmAsia News, Sept. 22, 2011). For this profile, we zoom in on the Bank of America Merrill Lynch Global Healthcare Conference, held Sept. 15-16 in London.

You may also be interested in...



Has Roche Set Up Celgene For Success In China?

Celgene is launching Revlimid in China and will go it alone without a local partner. Many consider the move curious, but some say companies such as Roche paved the way for Celgene.

Emerging Views On Emerging Markets: Sanford C. Bernstein & Co. Strategic Decisions Conference

PharmAsia News takes a closer look at presentations by BMS, Celgene, Lilly and Hospira.

Emerging Views On Emerging Markets: JP Morgan Healthcare Conference (Part 1 of 2)

Emerging markets continued to play a large role in company presentations during the industry’s largest investor conference. PharmAsia News takes a closer look.

Related Content

Latest News
See All
UsernamePublicRestriction

Register

SC076637

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel